Access to affordable healthcare and prescription drugs is an ongoing problem that affects a significant number of the ...

A new study examines how cost, side effects, and other factors influence whether people stop GLP-1s, while Noom cuts staff to ...

Public trust in a federal access program for the overdose drug Naloxone has been shaken after more than a year of shortages ...